Tuesday, September 12, 2017 2:18:52 PM
Concerned about the 90 day PE's missing clinical significance in light of strong trends and one year data strengthening.
Cash burn is very high with the multiple trials and additional ancillary non stroke trials i.e. Gvhd and other immunological disorders
OS and Float not too bad for a start up company
Do like FDA SPA and Fast track and other EU and Japan expeditious review status for unmet disease states
Like the 10's of Billions market they are pursuing for stroke, MI's and others
Not sure what the specific MOA for Multistem is? I know it inhibits inflammatory mediators in the spleen for subsequent inhibition to the brain as well as Brain site specific inhibition to the ischemic area of the brain.
I "LOVE" the potential for a 36 hour duration of treatment intervention over the SOC current 4 to 6 hour Thrombolytic treatment
Will there be an interim readout on the Stroke trials?
How long are these trials until full completion. Are they going to wait for the one year morbidity/Mortality data, or will that be post approval P4 - like data?
Is there a high likelihood of another cash raise/dilution and perhaps R/S? in your analysis and opinion
I like the resume's of Management and the Board
Would it be prudent to continue and watch for a more attractive pps entry? We are currently at the 80% of the 52 week high (2.22) low
Still have more DD to do. Always appreciate your views, analysis and opinion CARS...as well as the rest of this Board...PRO's and CON"s..Thank you in Advance.....PEARSBY
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM